bumetanide has been researched along with Acute Confusional Senile Dementia in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Bumetanide treatment of apoE4 mice without or with Aβ accumulation rescued electrophysiological, pathological, or cognitive deficits." | 1.62 | Experimental and real-world evidence supporting the computational repurposing of bumetanide for ( An, A; Balestra, ME; Bicak, M; Chang, W; Chaudhry, F; Chen, B; Chen, N; Choudhary, K; De Freitas, J; Glicksberg, BS; Grone, B; Hao, Y; Huang, Y; Jones, EAA; Kosti, I; Koutsodendris, N; Nova, P; Oskotsky, T; Paranjpe, I; Pineda, S; Sirota, M; Taubes, A; Wang, C; Yoon, SY; Zalocusky, KA; Zilberter, MY, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Taubes, A | 1 |
| Nova, P | 1 |
| Zalocusky, KA | 1 |
| Kosti, I | 1 |
| Bicak, M | 1 |
| Zilberter, MY | 1 |
| Hao, Y | 1 |
| Yoon, SY | 1 |
| Oskotsky, T | 1 |
| Pineda, S | 1 |
| Chen, B | 1 |
| Jones, EAA | 1 |
| Choudhary, K | 1 |
| Grone, B | 1 |
| Balestra, ME | 1 |
| Chaudhry, F | 1 |
| Paranjpe, I | 1 |
| De Freitas, J | 1 |
| Koutsodendris, N | 1 |
| Chen, N | 1 |
| Wang, C | 1 |
| Chang, W | 1 |
| An, A | 1 |
| Glicksberg, BS | 1 |
| Sirota, M | 1 |
| Huang, Y | 1 |
| Li, Z | 1 |
| Zhao, N | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase IIa, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Tolerability of Bumetanide in Patients With Alzheimer's Disease.[NCT06052163] | Phase 2 | 40 participants (Anticipated) | Interventional | 2023-10-15 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 other studies available for bumetanide and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Experimental and real-world evidence supporting the computational repurposing of bumetanide for
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apolipoprotein E4; Apolipoproteins E; Bumetanide; | 2021 |
A water pill against Alzheimer's disease.
Topics: Alzheimer Disease; Apolipoprotein E4; Bumetanide; Humans; Water | 2021 |